Festival of Genomics Boston - October 2017, Boston Convention Center

Bioline

Stand: E7
  • Sequencing
  • Epigenetics

Bioline is an evolving international company, which develops, manufactures and markets a wide range of specialized bio-research reagents that simplify, accelerate and improve life sciences research. Our vision is to position Bioline at the forefront of human, animal and plant health through continuous innovation.

Founded in 1992 and headquartered in London, UK, Bioline is an evolving international company and our mission is to provide customers with a range of products which are fast and easy to use, guaranteed to work and developed by scientists who understand what our customers are trying to achieve so they can focus on their scientific goals. At Bioline, we constantly strive to improve and to deliver high quality products which are the result of our strong commitment and investment in science. Bioline, wholly owned by Meridian Bioscience Inc. (Nasdaq: VIVO), operates as one multi-cultural global team with strong values.

Address

Edge Business Centre
Humber Rd
London
NW2 6EW
United Kingdom

Website

https://www.bioline.com/

Contact Exhibitor


Loading
  • Bioline recognizes the importance of adhering to a quality management system in the development, manufacture and supply of test components to the molecular diagnostic arena. We are committed to strengthening our relationships by meeting the quality standard our industrial partners need in their efforts to achieve test certification. Consequently, Bioline is delighted to announce that our production facilities in Berlin and research facilities in London are now certified to ISO 13485 quality standard. Our full range of industrial services includes custom assay development, bulk supply of test components, validation support, and private label OEM manufacture. 

1 Results
Loading
View all Exhibitors

Book Your Pass

  • Register for your FREE Festival pass   View
  • Poster pass £30 View

Exhibitors


 

Sign up to the mailing list for more information, and to receive the Front Line Genomics magazine

Sign Up